New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
07:16 EDTMYGNMyriad Genetics firing on all cylinders, says Cantor
After meeting with Myriad's management, Cantor thinks that the company could have significant opportunities from the diversification of its PROLARIS and Crescendo products in the near to medium term. The firm raised its price target on the stock to $42 from $39 and reiterates a Buy rating on the shares.
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use